For the Inventor, By the Inventor

Enter assignee name

Laboratori Baldacci S.p.a.

USPTO Granted Patents = 16

EPO Patents = 12

Forward Citations = 39

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Massimo Baldacci (13 out of 16 patents)

Luigi Fiume (3 out of 6 patents)

Alessandro Mattioli (3 out of 5 patents)

4. Corrado Busi (3 out of 5 patents)

5. Giulio Caccia (2 out of 2 patents)

6. Raffaella Scorza (1 out of 2 patents)

7. Marinella Roberti (1 out of 2 patents)

8. Bruno Macchia (1 out of 3 patents)

9. Aldo Balsamo (1 out of 3 patents)

10. Marco Macchia (1 out of 3 patents)

11. Mario Del Tacca (1 out of 3 patents)

12. Romano Danesi (1 out of 4 patents)

13. Ugo Baldacci (1 out of 1 patent)

14. Giuseppina D Stefano (1 out of 1 patent)

15. Antonio Marsili (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 12546756 - Mixture of isomers of aminaphtone, analytical method for identifying them and pharmaceutical composition comprising said isomers (2026-02-10),

2. 11865099 - Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof (2024-01-09),

3. 11213505 - Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof (2022-01-04),

4. 10456374 - Pyrrolidone carboxylic acid (PCA) for ophthalmic use (2019-10-29),

5. 10272067 - Pyrrolidone carboxylic acid (PCA) for ophthalmic use (2019-04-30),

6. 10028929 - Method of treating raynaud's disease secondary to connectivitis using aminaphtone (2018-07-24),

7. 8987503 - Process for the synthesis of aminaphtone (2015-03-24),

8. 6242433 - Geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions (2001-06-05),

9. 5594110 - Process of conjugation of antiviral nucleosides with lactosaminated (1997-01-14),

10. 5470965 - Complexable heterogenous oligosaccharides and alpha-hydosanes having (1995-11-28),

11. 5066676 - Sulfonamido derivative inhibiting the aldose reductase enzyme system and (1991-11-19),

12. 4927849 - Sulfonamido derivatives inhibiting the aldose reductase enzyme system (1990-05-22),

13. 4794170 - Method for the preparation of conjugates of (1988-12-27),

14. 4725672 - Conjugate of 9-(2-hydroxyethoxymethyl)-guanine with lactosaminated human (1988-02-16),

15. 4581371 - Pharmaceutical composition having immunomodulating activity (1986-04-08),

Company Overview

Laboratori Baldacci S.p.a., based in Pisa, Italy, specializes in the development and manufacturing of high-quality pharmaceutical products. The company focuses on innovative solutions in the fields of dermatology, gynecology, and other therapeutic areas, emphasizing research and development to enhance patient care. With a commitment to quality and efficacy, Laboratori Baldacci aims to meet the evolving needs of healthcare professionals and patients, contributing to advancements in medical treatments and health outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

16 Patents

#3 in Pisa

#579 in Italy

#37,868 in the World

Laboratori Baldacci S.p.a.

Forward Citations = 39

15 inventors:

Massimo Baldacci (13 out of 16 patents)

Luigi Fiume (3 out of 6 patents)

Alessandro Mattioli (3 out of 5 patents)

4. Corrado Busi (3 out of 5 patents)

5. Giulio Caccia (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Laboratori Baldacci S.p.a.. Retrieved from https://idiyas.com/company/laboratori-baldacci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…